There’s a proposal in Tallahassee right now that could make it easier for injection drug users to trade dirty needles for fresh ones — preventing the spread of HIV and Hepatitis C.
A trial project in Miami Dade County is the only legal needle exchange in Florida. The bill would let the other counties to create something similar.
There’s a spot along 11th street in Overtown in Miami that’s surrounded by a convergence of overpasses. And this time last year, a guy with heavy black arrows tattooed on his arms showed up there pretty regularly.
DURHAM — A federal judge has ordered North Carolina prisons to expand testing and treatment for hepatitis C, which kills more American than any other infectious disease.
The injunction follows a class-action lawsuit filed by three inmates who say thousands of incarcerated people in North Carolina are going undiagnosed due to a lack of universal hepatitis C testing. Hundreds with the liver infection are developing health complications while the state denies them potentially life-saving medication, the lawsuit states.
U.S. District Judge William Osteen Jr. issued a ruling Wednesday that calls for the N.C. Department of Public Safety to screen all inmates for hepatitis C, unless they opt out. The state’s current policy only calls for testing people with risk factors.
On the threshold of obtaining results from a clinical trial of a newly developed vaccine against hepatitis C virus (HCV) in a population at-risk for infection, investigators have described the challenges they have encountered and the prospects for success.
“A potential new vaccine to prevent HCV infection has been tested in Baltimore and at two other sites in the US, and the results of that trial will be available by summer,” Andrea Cox, MD, PhD, Professor of Medicine and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, told MD Magazine®.
“We are hopeful that this vaccine will be able to protect against HCV and stem the rising tide of HCV infections in the US,” she said.
According to a study published in Hepatology, small dense LDL cholesterol independently predicted cardiovascular disease events among liver transplant recipients, according to a study published in Hepatology.
“The present study employs detailed lipoprotein sub-particles to link specific proteins with CVD outcomes using a prospective cohort and provides valuable information that can be readily incorporated into clinical practice to hopefully improve clinical outcomes,” Mohammad B. Siddiqui, MD, from the Virginia Commonwealth University, and colleagues wrote. “The generation of the atherogenic [small dense LDL cholesterol (sdLDL-C)] likely results from insulin resistance, exposure to chronic immunosuppression and fatty liver after LT.”
The researchers included 130 liver transplant recipients in the study. The primary etiologies for liver transplantation included hepatitis C, nonalcoholic steatohepatitis and alcohol-related cirrhosis. The prevalence of cardiometabolic conditions at baseline included diabetes (35%), hypertension (82%), and dyslipidemia (40%).
Alcohol and other substance-use problems take enormous psychological and societal tolls on millions of Americans. Now a study from the Massachusetts General Hospital (MGH) Recovery Research Institute shows that more than a third of individuals who consider themselves in recovery from an alcohol or other substance use disorder continue to suffer from chronic physical disease. The study, published online March 20 in the Journal of Addiction Medicine, is the first to look at the national prevalence of medical conditions that are commonly caused or exacerbated by excessive and chronic alcohol and other drug use among people in addiction recovery.
“The prodigious psychological, social and interpersonal impact of excessive and chronic alcohol and other drug use is well characterized,” says lead and corresponding author David Eddie, PhD, research scientist at the Recovery Research Institute. “Less well appreciated is the physical disease burden, especially among those who have successfully resolved a significant substance use problem.”
Incorporating data from the landmark 2017 National Recovery Survey, the current study examined information from a nationally representative sample of more than 2,000 U.S. adults describing themselves as in recovery from problems with the use of alcohol, cannabis, opioids, stimulants or other drugs. Of these, 37 percent had been diagnosed with one or more of nine alcohol- and drug-exacerbated diseases and health conditions: liver disease, tuberculosis (TB), HIV/AIDS or other sexually transmitted infections (STIs), cancer, hepatitis C, chronic obstructive pulmonary disease (COPD), heart disease and diabetes. The presence of these diseases was shown to be associated with significant reductions in participants’ quality of life, and all are known to reduce life expectancy.
As state administrators throughout Appalachia grapple with mounting health care costs, a new resource is offering assistance to policymakers by taking lessons from success stories outside of the health sector.
The study examines successful policies outside the health care sector that states, including those in the Appalachian region, have adopted to improve their communities’ health and well-being outcomes while reducing health care costs. Among those included are universal pre-kindergarten, rapid rehousing legislation and housing rehabilitation loans and grants, syringe-exchange programs and tobacco and alcohol taxes.